Drug Approval | November 17, 2021
Alembic JV receives final approval for Mupirocin cream
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
The centre has an initial capacity of 500 FTEs
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
Subscribe To Our Newsletter & Stay Updated
